Michelle R. Lofwall

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

Michelle R. Lofwall, Sharon Walsh, Edward V. Nunes et al. · JAMA Internal Medicine · 2018 · 249 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis

Margaret Haney, Robert Malcolm, Shanna Babalonis et al. · Neuropsychopharmacology · 2015 · 205 citations · Full text

Medicine, Pharmacology, Psychopharmacology +1

Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug Users

Jennifer R. Havens, Michelle R. Lofwall, Simon D. W. Frost et al. · American Journal of Public Health · 2012 · 190 citations · Full text

Public Health, Community Health, Epidemiology +15

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

Kevin M. Gray, Susan C. Sonne, Erin A. McClure et al. · Drug and Alcohol Dependence · 2017 · 155 citations · Full text

Medicine, Pharmacology, Psychiatry +11

The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

Sharon Walsh, Nabila El‐Bassel, Rebecca D. Jackson et al. · Drug and Alcohol Dependence · 2020 · 153 citations · Full text

Public Health, Community Health, Preventive Medicine +12